United States Biotechnology & Medical Research

Urogen Pharma Ltd (URGN)

Track

Track

Urogen Pharma Ltd experienced significant insider trading activity recently, characterized by net sales totaling approximately 2.85 million dollars. Executives, primarily the Chief Medical Officer, executed multiple planned divestments following a strong 48.5 percent stock price increase over ninety days. These transactions occurred after a positive earnings report, reflecting ongoing liquidity events by key leadership personnel.
Ticker: URGN Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Urogen Pharma Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
345.89
Quantity 34,269 -24.2%
Value US$790,991
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
401.73
Quantity 52,624 -13.1%
Value US$1,020,730
2.1
Mark Schoenberg Officer Officer
Transaction date
Proposed sale
Price
58.27
Quantity 89,320
Value US$841,205
2.0
Jason Smith Officer Officer
Transaction date
Proposed sale
Price
44.09
Quantity 1,000
Value US$100,000
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
47.05
Quantity 60,677 -50.7%
Value US$2,854,853
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
47.67
Quantity 60,677
Value US$2,892,242
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
40.00
Quantity 10,000 -7.7%
Value US$400,000
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
40.00
Quantity 10,000
Value US$400,008
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
35.01
Quantity 10,000 -7.2%
Value US$350,100
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
35.01
Quantity 10,000
Value US$350,143
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
27.30
Quantity 5,222 -3.6%
Value US$142,561
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
26.85
Quantity 5,222
Value US$140,211
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
30.00
Quantity 10,000 -6.9%
Value US$300,000
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
30.00
Quantity 10,000
Value US$300,048
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
19.69
Quantity 3,217 -5.5%
Value US$63,343
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
19.69
Quantity 1,608 -3.0%
Value US$31,662
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
19.69
Quantity 2,654 -4.8%
Value US$52,257
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
19.69
Quantity 3,686 -2.5%
Value US$72,577
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
19.69
Quantity 1,843 -1.2%
Value US$36,289
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
19.69
Quantity 3,686 -2.5%
Value US$72,577
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
19.69
Quantity 1,843 -1.2%
Value US$36,289
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
19.69
Quantity 1,844 -1.2%
Value US$36,308
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
19.61
Quantity 13,333
Value US$261,460
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Planned sale
Price
25.00
Quantity 10,000 -6.7%
Value US$250,000
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
25.00
Quantity 10,000
Value US$250,005
2.2
Degnan Chris Chief Financial Officer Officer
Transaction date
Sale
Price
16.85
Quantity 2,203 -49.1%
Value US$37,121
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
18.88
Quantity 871
Value US$16,444
2.0
Smith Jason Drew Officer Officer
Transaction date
Proposed sale
Price
18.88
Quantity 1,520
Value US$28,698
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
19.11
Quantity 871 -0.6%
Value US$16,645
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
19.11
Quantity 1,520 -3.4%
Value US$29,047
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
17.69
Quantity 10,000 -6.3%
Value US$176,900
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
19.14
Quantity 5,149 -3.2%
Value US$98,552
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
19.14
Quantity 7,522 -15.3%
Value US$143,971
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
18.95
Quantity 5,149
Value US$97,574
2.0
Smith Jason Drew Officer Officer
Transaction date
Proposed sale
Price
18.95
Quantity 7,522
Value US$142,542
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
7.37
Quantity 5,162 -3.3%
Value US$38,044
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
7.37
Quantity 5,162
Value US$38,044
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
11.14
Quantity 1,896 -1.3%
Value US$21,121
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
11.14
Quantity 1,896 -1.3%
Value US$21,121
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
11.14
Quantity 759 -0.5%
Value US$8,455
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
11.14
Quantity 2,767 -7.8%
Value US$30,824
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
11.14
Quantity 3,354 -10.1%
Value US$37,364
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
11.14
Quantity 1,258 -4.5%
Value US$14,014
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
13.08
Quantity 1,521 -5.7%
Value US$19,895
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
13.08
Quantity 859 -0.6%
Value US$11,236
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
13.23
Quantity 859
Value US$11,365
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
13.21
Quantity 5,153
Value US$68,071
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
13.08
Quantity 5,153 -3.4%
Value US$67,401
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
14.05
Quantity 12,000 -7.9%
Value US$168,600
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
14.05
Quantity 12,000
Value US$168,600
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
15.74
Quantity 3,328 -12.4%
Value US$52,383
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
15.74
Quantity 1,248 -5.9%
Value US$19,644
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
15.74
Quantity 417 -2.2%
Value US$6,564
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
15.74
Quantity 1,894 -1.2%
Value US$29,812
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
15.74
Quantity 758 -0.5%
Value US$11,931
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
15.74
Quantity 1,137 -0.8%
Value US$17,896
2.1
Schoenberg Mark Officer Officer
Transaction date
Proposed sale
Price
15.83
Quantity 3,789
Value US$59,980
2.0
Smith Jason Drew Officer Officer
Transaction date
Proposed sale
Price
15.83
Quantity 4,993
Value US$79,039
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
18.01
Quantity 3,800 -17.1%
Value US$68,438
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
10.12
Quantity 661 -0.4%
Value US$6,689
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
10.12
Quantity 991 -0.7%
Value US$10,029
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
10.12
Quantity 248 -0.2%
Value US$2,510
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
10.12
Quantity 1,227 -8.1%
Value US$12,417
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
10.12
Quantity 409 -3.1%
Value US$4,139
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
11.85
Quantity 258 -1.1%
Value US$3,057
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
7.21
Quantity 3,606 -22.8%
Value US$25,999
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
7.81
Quantity 259 -1.1%
Value US$2,023
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
6.62
Quantity 254 -1.1%
Value US$1,681
2.0
Smith Jason Drew General Counsel Officer
Transaction date
Sale
Price
7.58
Quantity 414 -5.3%
Value US$3,138
2.2
Barrett Elizabeth A. Chief Executive Officer Officer
Transaction date
Sale
Price
7.58
Quantity 5,960 -1.9%
Value US$45,177
2.2
Barrett Elizabeth A. Chief Executive Officer Officer
Transaction date
Sale
Price
7.58
Quantity 2,235 -0.7%
Value US$16,941
3.5
Henderson Molly Chief Financial Officer Officer
Transaction date
Sale
Price
7.58
Quantity 331 -5.9%
Value US$2,509
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
7.58
Quantity 1,099 -4.5%
Value US$8,330
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
7.58
Quantity 275 -1.2%
Value US$2,084
2.1
Schoenberg Mark Chief Medical Officer Officer
Transaction date
Sale
Price
8.09
Quantity 111 -0.5%
Value US$898
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-09 2026-09-08 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
34,269 -24.2%
345.89
US$790,991 		34,269 -24.2% 345.89 US$790,991
2026-09-09 2026-09-08 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
52,624 -13.1%
401.73
US$1,020,730 		52,624 -13.1% 401.73 US$1,020,730
2026-09-09 2026-09-08 PrS Proposed sale
2.1
Mark Schoenberg

Officer

Officer
89,320
58.27
US$841,205 		89,320 58.27 US$841,205
2026-09-09 2026-09-08 PrS Proposed sale
2.0
Jason Smith

Officer

Officer
1,000
44.09
US$100,000 		1,000 44.09 US$100,000
2026-08-24 2026-08-20 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
60,677 -50.7%
47.05
US$2,854,853 		60,677 -50.7% 47.05 US$2,854,853
2026-08-20 2026-08-20 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
60,677
47.67
US$2,892,242 		60,677 47.67 US$2,892,242
2026-07-10 2026-07-09 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -7.7%
40.00
US$400,000 		10,000 -7.7% 40.00 US$400,000
2026-07-09 2026-07-09 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
10,000
40.00
US$400,008 		10,000 40.00 US$400,008
2026-06-24 2026-06-22 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -7.2%
35.01
US$350,100 		10,000 -7.2% 35.01 US$350,100
2026-06-22 2026-06-22 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
10,000
35.01
US$350,143 		10,000 35.01 US$350,143
2026-06-09 2026-06-08 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,222 -3.6%
27.30
US$142,561 		5,222 -3.6% 27.30 US$142,561
2026-06-09 2026-06-08 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,222
26.85
US$140,211 		5,222 26.85 US$140,211
2026-05-11 2026-05-08 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -6.9%
30.00
US$300,000 		10,000 -6.9% 30.00 US$300,000
2026-05-08 2026-05-08 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
10,000
30.00
US$300,048 		10,000 30.00 US$300,048
2026-02-11 2026-02-03 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,217 -5.5%
19.69
US$63,343 		3,217 -5.5% 19.69 US$63,343
2026-02-11 2026-02-03 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,608 -3.0%
19.69
US$31,662 		1,608 -3.0% 19.69 US$31,662
2026-02-11 2026-02-03 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
2,654 -4.8%
19.69
US$52,257 		2,654 -4.8% 19.69 US$52,257
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
3,686 -2.5%
19.69
US$72,577 		3,686 -2.5% 19.69 US$72,577
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,843 -1.2%
19.69
US$36,289 		1,843 -1.2% 19.69 US$36,289
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
3,686 -2.5%
19.69
US$72,577 		3,686 -2.5% 19.69 US$72,577
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,843 -1.2%
19.69
US$36,289 		1,843 -1.2% 19.69 US$36,289
2026-02-04 2026-02-03 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,844 -1.2%
19.69
US$36,308 		1,844 -1.2% 19.69 US$36,308
2026-02-03 2026-02-02 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
13,333
19.61
US$261,460 		13,333 19.61 US$261,460
2025-11-20 2025-11-19 PlS Planned sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -6.7%
25.00
US$250,000 		10,000 -6.7% 25.00 US$250,000
2025-11-19 2025-11-19 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
10,000
25.00
US$250,005 		10,000 25.00 US$250,005
2025-10-09 2025-10-08 S Sale
2.2
Degnan Chris

Chief Financial Officer

Officer
2,203 -49.1%
16.85
US$37,121 		2,203 -49.1% 16.85 US$37,121
2025-09-09 2025-09-08 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
871
18.88
US$16,444 		871 18.88 US$16,444
2025-09-09 2025-09-08 PrS Proposed sale
2.0
Smith Jason Drew

Officer

Officer
1,520
18.88
US$28,698 		1,520 18.88 US$28,698
2025-09-09 2025-09-08 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
871 -0.6%
19.11
US$16,645 		871 -0.6% 19.11 US$16,645
2025-09-09 2025-09-08 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,520 -3.4%
19.11
US$29,047 		1,520 -3.4% 19.11 US$29,047
2025-08-13 2025-08-11 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
10,000 -6.3%
17.69
US$176,900 		10,000 -6.3% 17.69 US$176,900
2025-07-30 2025-07-28 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,149 -3.2%
19.14
US$98,552 		5,149 -3.2% 19.14 US$98,552
2025-07-30 2025-07-28 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
7,522 -15.3%
19.14
US$143,971 		7,522 -15.3% 19.14 US$143,971
2025-07-29 2025-07-28 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,149
18.95
US$97,574 		5,149 18.95 US$97,574
2025-07-29 2025-07-28 PrS Proposed sale
2.0
Smith Jason Drew

Officer

Officer
7,522
18.95
US$142,542 		7,522 18.95 US$142,542
2025-06-11 2025-06-09 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,162 -3.3%
7.37
US$38,044 		5,162 -3.3% 7.37 US$38,044
2025-06-10 2025-06-09 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,162
7.37
US$38,044 		5,162 7.37 US$38,044
2025-02-04 2025-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,896 -1.3%
11.14
US$21,121 		1,896 -1.3% 11.14 US$21,121
2025-02-04 2025-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,896 -1.3%
11.14
US$21,121 		1,896 -1.3% 11.14 US$21,121
2025-02-04 2025-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
759 -0.5%
11.14
US$8,455 		759 -0.5% 11.14 US$8,455
2025-02-04 2025-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
2,767 -7.8%
11.14
US$30,824 		2,767 -7.8% 11.14 US$30,824
2025-02-04 2025-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,354 -10.1%
11.14
US$37,364 		3,354 -10.1% 11.14 US$37,364
2025-02-04 2025-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,258 -4.5%
11.14
US$14,014 		1,258 -4.5% 11.14 US$14,014
2024-09-12 2024-09-09 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,521 -5.7%
13.08
US$19,895 		1,521 -5.7% 13.08 US$19,895
2024-09-12 2024-09-09 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
859 -0.6%
13.08
US$11,236 		859 -0.6% 13.08 US$11,236
2024-09-10 2024-09-09 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
859
13.23
US$11,365 		859 13.23 US$11,365
2024-06-11 2024-06-10 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
5,153
13.21
US$68,071 		5,153 13.21 US$68,071
2024-06-11 2024-06-10 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
5,153 -3.4%
13.08
US$67,401 		5,153 -3.4% 13.08 US$67,401
2024-03-20 2024-03-18 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
12,000 -7.9%
14.05
US$168,600 		12,000 -7.9% 14.05 US$168,600
2024-03-18 2024-03-18 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
12,000
14.05
US$168,600 		12,000 14.05 US$168,600
2024-02-02 2024-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,328 -12.4%
15.74
US$52,383 		3,328 -12.4% 15.74 US$52,383
2024-02-02 2024-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,248 -5.9%
15.74
US$19,644 		1,248 -5.9% 15.74 US$19,644
2024-02-02 2024-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
417 -2.2%
15.74
US$6,564 		417 -2.2% 15.74 US$6,564
2024-02-02 2024-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,894 -1.2%
15.74
US$29,812 		1,894 -1.2% 15.74 US$29,812
2024-02-02 2024-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
758 -0.5%
15.74
US$11,931 		758 -0.5% 15.74 US$11,931
2024-02-02 2024-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,137 -0.8%
15.74
US$17,896 		1,137 -0.8% 15.74 US$17,896
2024-02-01 2024-01-31 PrS Proposed sale
2.1
Schoenberg Mark

Officer

Officer
3,789
15.83
US$59,980 		3,789 15.83 US$59,980
2024-02-01 2024-01-31 PrS Proposed sale
2.0
Smith Jason Drew

Officer

Officer
4,993
15.83
US$79,039 		4,993 15.83 US$79,039
2023-09-05 2023-08-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,800 -17.1%
18.01
US$68,438 		3,800 -17.1% 18.01 US$68,438
2023-02-02 2023-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
661 -0.4%
10.12
US$6,689 		661 -0.4% 10.12 US$6,689
2023-02-02 2023-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
991 -0.7%
10.12
US$10,029 		991 -0.7% 10.12 US$10,029
2023-02-02 2023-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
248 -0.2%
10.12
US$2,510 		248 -0.2% 10.12 US$2,510
2023-02-02 2023-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
1,227 -8.1%
10.12
US$12,417 		1,227 -8.1% 10.12 US$12,417
2023-02-02 2023-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
409 -3.1%
10.12
US$4,139 		409 -3.1% 10.12 US$4,139
2022-11-02 2022-10-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
258 -1.1%
11.85
US$3,057 		258 -1.1% 11.85 US$3,057
2022-09-02 2022-08-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
3,606 -22.8%
7.21
US$25,999 		3,606 -22.8% 7.21 US$25,999
2022-08-25 2022-08-01 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
259 -1.1%
7.81
US$2,023 		259 -1.1% 7.81 US$2,023
2022-05-03 2022-04-30 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
254 -1.1%
6.62
US$1,681 		254 -1.1% 6.62 US$1,681
2022-02-02 2022-01-31 S Sale
2.0
Smith Jason Drew

General Counsel

Officer
414 -5.3%
7.58
US$3,138 		414 -5.3% 7.58 US$3,138
2022-02-02 2022-01-31 S Sale
2.2
Barrett Elizabeth A.

Chief Executive Officer

Officer
5,960 -1.9%
7.58
US$45,177 		5,960 -1.9% 7.58 US$45,177
2022-02-02 2022-01-31 S Sale
2.2
Barrett Elizabeth A.

Chief Executive Officer

Officer
2,235 -0.7%
7.58
US$16,941 		2,235 -0.7% 7.58 US$16,941
2022-02-02 2022-01-31 S Sale
3.5
Henderson Molly

Chief Financial Officer

Officer
331 -5.9%
7.58
US$2,509 		331 -5.9% 7.58 US$2,509
2022-02-02 2022-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
1,099 -4.5%
7.58
US$8,330 		1,099 -4.5% 7.58 US$8,330
2022-02-02 2022-01-31 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
275 -1.2%
7.58
US$2,084 		275 -1.2% 7.58 US$2,084
2022-01-28 2022-01-26 S Sale
2.1
Schoenberg Mark

Chief Medical Officer

Officer
111 -0.5%
8.09
US$898 		111 -0.5% 8.09 US$898
Explore more

More insider trading research around Urogen Pharma Ltd

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America